Home Sequential Compression Devices Market Size, Share, and Industry Analysis, By Product Type (Alternate Sequential Compression Device and Simultaneous Sequential Compression Device), By Application (Deep Vein Thrombosis (DVT), Lymphedema, Pulmonary Embolism (PE), and Others), and Regional Forecast, 2025-2032

Home sequential compression devices are medical devices designed to improve circulatory function in individuals with poor circulatory flow. These devices are used for the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) by applying intermittent pneumatic compression to the extremities. They are typically used at home under the guidance of a healthcare provider or a trained caregiver.

Home sequential compression devices apply intermittent pneumatic pressure to the extremities, improving circulatory function and preventing DVT and PE. They have inflatable sleeves that inflate sequentially, promoting venous return. Benefits include DVT and PE prevention, lymphedema management, CVI treatment, portability, and ease of use. These devices increase the tissue plasminogen activator, a protein involved in blood clot breakdown. They provide a non-invasive and low-risk alternative to medication, improving the accessibility to effective treatment for cardiovascular diseases.

The market growth is primarily attributed to the high burden of lymphatic and venous disorders such as lymphedema, deep vein thrombosis (DVT), and chronic venous insufficiency (CVI). Home sequential compression devices are effective in preventing DVT by improving blood circulation and reducing blood clot formation. In addition, these devices help manage lymphedema by improving lymphatic and vascular flow, reducing swelling, and promoting wound healing. This is expected to drive their adoption and market growth during the forecast period.

• For instance, as of January 2024, the National Center for Biotechnology Information (NCBI) reported that chronic venous insufficiency is a prevalent disease worldwide.

The awareness of the importance of circulatory health and the need for effective management of circulatory disorders is rising significantly due to the understanding of the risks associated with blood clots, such as pulmonary embolism (PE), deep vein thrombosis (DVT), and chronic venous insufficiency (CVI) globally. This is expected to increase the adoption of these devices, thereby boosting market growth in the coming years.

Moreover, the improved technology and portability of sequential compression devices make them more accessible and user-friendly. Such improvements in technologies are propelling the demand for home sequential compression devices for the prevention of several complications associated with lymphatic and venous disorders, which is expected to surge the market growth in the coming years.

The COVID-19 pandemic had a significant impact on the home sequential compression devices market. The pandemic led to a surge in demand for home-based diagnostic and therapeutic devices, including home sequential compression devices, due to the fear of hospital-acquired infections. Several individuals globally transitioned toward these devices for the treatment of deep vein thrombosis and lymphedema during this period, thereby supporting the growth of the home sequential compression devices market in 2020.

Segmentation

Key Insights

The report covers the following key insights:

• Incidence of Key Diseases, By Key Countries/Region, 2023
• New Product Launches By Key Players
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Impact of COVID-19 on the Market

Analysis by Application

Based on the application, the market is divided into deep vein thrombosis (DVT), lymphedema, pulmonary embolism (PE), and others. The deep vein thrombosis (DVT) segment is projected to hold a significant share of the global home sequential compression devices market during the forecast period. The growth of this segment is attributed to the high burden of this disease across the globe. The home sequential compression devices help reduce the risk of deep vein thrombosis (DVT) by providing hospital-quality vascular compression therapy at home. In addition, it offers more comfort, convenience, and ease of use, which is expected to fuel its demand in the treatment of such conditions, thereby propelling the segment's growth in the coming years.

On the other hand, the lymphedema segment is anticipated to grow at a noteworthy CAGR during the forecast period. The home sequential compression devices help in the treatment of lymphedema by improving lymphatic and vascular flow to reduce swelling and edema. The significance of these devices in improving the quality of life in lymphedema patients is stimulating the key players to conduct clinical studies to support the use of such products. This is projected to boost the segment growth in the coming years.

• For instance, in May 2024, Tactile Medical announced that 251 participants in the U.S. recruited at their four VA medical centers from 2016 to 2022 were instructed to use the Flexitouch for lymphedema along with other conservative treatments as prescribed by their physician. The completion of this study reported that the quality of life in lymphedema patients increased by 6.2% to 6.9%.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the home sequential compression devices market during the forecast period. The market growth is attributed to the high burden of venous disorders such as chronic venous insufficiency in the region. The home sequential compression devices increase the blood flow and reduce blood pressure, improving the outcomes in such diseases. In consideration of these benefits, several key players are focusing on expanding the availability of such devices in the region. This is expected to boost the adoption of such devices, thereby fueling the market growth in the region.

Asia Pacific is projected to grow at a significant CAGR during the forecast period. The growth of the region is mainly attributed to the rising prevalence of diabetes. Diabetes is a considerable risk factor for deep vein thrombosis (DVT), lymphedema, and chronic venous insufficiency (CVI), which are key applications of these devices. Furthermore, the growing demand for non-invasive treatment in the region is also driving the demand for home sequential compression devices, as these devices offer a convenient and less invasive alternative to traditional therapies. These factors are projected to fuel the regional market growth in the forthcoming years.

• For instance, as of June 2024, the World Health Organization (WHO) reports that there are an estimated 77 million individuals above the age of 18 years currently who have diabetes (type 2), and around 25 million are prediabetics.

Key Players Covered

The market consists of significant players such as Cardinal Health, Enovis Corporation, BIO COMPRESSION SYSTEMS, DS MAREF CO., LTD., PRECISION MEDICAL PRODUCTS, INC., AIROS Medical, Inc., Mego Afek Ltd., and Tactile Medical.

Key Industry Developments

• In September 2023, AIROS Medical, Inc. launched AIROS 6P, a sequential compression device to treat abdominal, pelvic, and leg swelling.
• In April 2023, AIROS Medical, Inc. received (FDA) 510(k) clearance for AIROS 8P Sequential Compression Therapy device and garment system to treat lymphedema in the lower legs, back, abdomen, pelvic, and hip areas.
• In April 2022, KOYA MEDICAL launched the Dayspring active compression system to treat lymphedema and venous diseases in the lower extremities in the U.S.